In its many embodiments, the present invention relates to a novel class of substituted bicyclic piperidinyl- and piperazinylsulfonamide compounds useful to inhibit 11β-hydroxysteroid dehydrogenase type-I, pharmaceutical compositions containing the compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the expression of 11β-hydroxysteroid dehydrogenase type-I using such compounds or pharmaceutical compositions.
在其多种实施方式中,本发明涉及一种新型的取代的双环
哌啶基和
哌嗪基磺酰胺化合物,用于抑制11β-羟基类
固醇脱氢酶I型,包含该化合物的制药组合物以及使用该化合物或制药组合物治疗、预防、抑制或改善与11β-羟基类
固醇脱氢酶I型表达相关的一个或多个病症的方法。